UNSPSC 51101940: Cycloguanil embonate

This classification denotes an antimalarial and folic acid antagonist with the molecular formula C23H16O6.2C11H14ClN5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TCO0SY4N3D, chemically known as 4,6-diamino-1-(p-chlorophenyl)-1,2-dihydro-2,2-dimethyl-s-triazine pamoate but more generally known as cycloguanil embonate, which bears US NIH Compound Identifier 11870. European Medicines Agency schedules Cycloguanil embonate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06853MIG.

World Health Organization schedules cycloguanil embonate in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule cycloguanil embonate under HS 29336980 and SITC 51576. SMILES: CC1(N=C(N=C(N1C2CCC(CC2)CL)N)N)C.CC1(N=C(N=C(N1C2CCC(CC2)CL)N)N)C.C1CCC2C(C1)CC(C(C2CC3C4CCCCC4CC(C3O)C(=O)O)O)C(=O)O

UNSPSC 51101940 Cycloguanil embonate is a Commodity code nominally designating a specific antimalarial pharmaceutical ingredient, but state and local opportunities posted under this code do not reflect procurement of cycloguanil embonate itself. Instead, the recent solicitations tagged to this code cover broader pharmaceutical and medical supply procurement — including naloxone, generic multi-source pharmaceuticals, over-the-counter products, and emergency medical supplies for fire and rescue operations. The code's nominal scope and the actual work being solicited show material misalignment; the opportunities reflect state and local health departments, transit authorities, and municipal emergency services purchasing finished pharmaceutical products, medical consumables, and pharmacy benefit program services rather than a specific active pharmaceutical ingredient. Issuing bodies include county health departments (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), municipal fire departments (City of Tampa), and cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving multiple state and local members). The mix suggests health-system and emergency-services procurement rather than pharmaceutical manufacturing or ingredient supply.

Recent opportunities span Florida, Texas, Minnesota, and Oregon. Representative solicitations include Seminole County's IFB60459723LAS seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023 (IFB); the City of Tampa's bid 26-P-00145 for 169 line items of medical and first aid supplies to the Tampa Fire Department Rescue Division with a response deadline of March 13, 2026 (sealed bid) and an estimated contract value of $700,000; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026, serving participating state and local government facilities across Minnesota and Oregon. The Texas Health and Human Services Commission also issued RFI HHS0017013 in April 2026 seeking vendor capabilities for direct-to-manufacturer prescription programs. Code misalignment is substantial — the cycloguanil embonate Commodity code does not reliably identify opportunities in this pharmaceutical and medical-supply family.